跳至主要内容
临床试验/NCT01384643
NCT01384643已完成4 期

Effect of Propofol on Renal Injury in Patients Undergoing Valvular Heart Surgery: A Prospective, Randomized Controlled Trial

Yonsei University1 个研究点 分布在 1 个国家目标入组 112 人开始时间: 2011年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
112
试验地点
1
主要终点
Serum creatinine

研究概览

简要总结

Ischemia/reperfusion (I/R)-induced acute kidney injury is a serious complication affecting patient outcome following cardiovascular surgeries. Propofol, an intravenously administered anesthetic with antioxidant properties, protects organs from I/R injury. This study aimed to investigate the ability of propofol to protect kidneys against I/R injury in the patients undergoing valvular heart surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing valvular heart surgery.
  • Age: 20~75.

排除标准

  • Emergency operation.
  • Patients with vitamin E or vitamin C within 5 days before surgery.
  • Patients with preoperative C-reactive protein (CRP) > 16 mg/L.
  • Patients with serum creatinine ≥ 2.0 mg/dL
  • Patients under hemodialysis.
  • Patients with acute myocardial infarction within 1 week before surgery

研究组 & 干预措施

Propofol group

Experimental

干预措施: Propofol (Drug)

Control group

Placebo Comparator

干预措施: Propofol (Drug)

结局指标

主要结局

Serum creatinine

时间窗: incidence of AKI during 48 hours after the surgery incidence of AKI

Comparison of serum creatinine elevation after surgery between Propofol and Control group.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验